• Parkinson’s UK partners with UCL on phase II trial pharmatimes
    October 28, 2020
    Parkinson’s UK has partnered with University College London (UCL) and will invest £1m in a phase II clinical trial to investigate if the drug ondansetron can alleviate hallucinations in people with Parkinson’s disease.
  • ‘One size fits all’ medication approach doesn’t work in pregnancy University of South Australia
    September 24, 2020
    New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.
PharmaSources Customer Service